Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Live double combined lactobacillus capsule for bacterial vaginosis – Phase II
CTR20210050Phase 2Completed
- Sponsor
- Longchuangji Pharmaceutical
- Start
- Jan 2021
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of live double combined lactobacillus in bacterial vaginosis (BV), sponsored by Longchuangji Pharmaceutical. Started Jan 2021; status: completed.
02
Drugs
live double combined lactobacillus
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on CTR20210050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210050.